-

Flatiron Health Appoints Nina Chavez, Former COO at New Mexico Cancer Center, as Senior Advisor

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced that Nina Chavez, formerly chief operating officer at New Mexico Oncology Hematology Consultants (NMOHC) at the New Mexico Cancer Center (NMCC), has joined Flatiron as a senior advisor. In this role, Nina will serve as a subject matter expert in value-based care and clinical practice transformation. She will be responsible for creating and implementing solutions to help practices succeed in the dynamic oncology marketplace.

Prior to joining Flatiron, Nina provided leadership and change management to NMCC to promote quality, innovation and clinical excellence. Reporting to the CEO, she helped shape the practice’s strategic direction, to build a top-performing team of 150+ staff and 22+ physicians and APPs. With her team, Nina participated in the expansion of NMCC’s capabilities beyond medical and radiation oncology, creating a multispecialty center offering rheumatology, primary care, palliative care, clinical research and internal medicine to help attract the right patient and payer mix.

“As the complexity of our community oncology landscape, competitive dynamics, and regulatory environment intensifies, it is increasingly important that Flatiron supports practices to drive financial and operational success beyond our core technology and service offerings,” said Carolyn Starrett, SVP of Provider Solutions. “Nina will offer Flatiron’s practices support in the community oncology space by leveraging her 16 years of experience in achieving cancer center business operational excellence.”

Nina participated in the leadership of the effort to transform NMCC into a level III oncology medical home with the National Committee for Quality Assurance, triggering participation in the Oncology Care Model with CMS and increasing Medicare reimbursement in quality adjustments and performance-based payments. She is considered a leading expert in USP800 and dispensing clinic operations, speaking at several national conferences over the years.

Nina previously served on the boards of the Association of Community Cancer Centers, and the Coalition of Hematology and Oncology Practices. Additionally, she is a fellow with the American College of Medical Practice Executives.

“After years of partnership and collaboration, I am excited to be joining Flatiron Health, a company that is dedicated to supporting community oncology,” said Nina Chavez. “I am looking forward to the opportunities that lay ahead to support practice leadership in their efforts to navigate community oncology in the ever-changing healthcare environment.”

For more information about Flatiron’s leading technology platform in community oncology, click here.

About Flatiron Health

Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care. Our platform enables cancer researchers and care providers to learn from the experience of every patient. Currently, Flatiron partners with over 280 community cancer practices, seven major academic research centers and over 15 of the top therapeutic oncology companies. For more information, please visit www.flatiron.com or follow us @FlatironHealth.

Contacts

Jenny Edelston
press@flatiron.com

Flatiron Health

Details
Headquarters: New York, NY
CEO: Carolyn Starrett
Employees: 2,500
Organization: PRI

Release Versions

Contacts

Jenny Edelston
press@flatiron.com

More News From Flatiron Health

Flatiron Health Attends the 2026 American Society of Genitourinary Cancers Symposium to Answer Oncology's Most Critical Questions

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced its presence at the American Society of Genitourinary Cancers Symposium happening from February 26-28, 2026, in San Francisco, California. Flatiron's real-world data and research capabilities are featured across multiple presentations, including 6 research acceptances spanning genitourinary cancers. A cornerstone of Flatiron’s presence at ASCO GU 2026 is the global prostate cancer and bladder cancer Panoramic datasets, which draw from o...

Flatiron Launches First-of-Its-Kind AI-Powered Global Prostate Cancer Datasets

NEW YORK--(BUSINESS WIRE)--Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data, today announced their first Panoramic datasets in the UK and Germany for patients with prostate cancer. Globally, prostate cancer affects nearly 1.5 million patients annually and has a rapidly evolving treatment landscape, yet real-world evidence remains limited and infeasible to study across international borders. Flatiron is the first and on...

Flatiron Health Names New Chief Business, Technology, and Product Leaders

NEW YORK--(BUSINESS WIRE)--Flatiron Health is pleased to announce three significant appointments to its Executive Team, reflecting the critical, enterprise-level responsibilities these leaders have assumed and the company’s evolving direction. Michael Bierl will serve as Chief Business Officer, Allison Candido will serve as Chief Technology Officer, and Kate Estep will serve as Chief Product Officer. With decades of combined experience, Bierl, Candido, and Estep bring the leadership and experti...
Back to Newsroom